Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) is set to start offering medical cannabis educational services in over 600 independent pharmacies across Ontario.
The producer, which specializes in hard-pill cannabinoid formulations, said Wednesday it signed an agreement with OnPharm-United, a network of independent pharmacy owners. The deal involves expanding access to medical cannabis programs, services, as well as teaching people how to access Canntab products via their website.
Canntab sells THC and CBD formulations on the medical and recreational markets, and holds a processing and sales licence for medical cannabis as well as a research licence.
OnPharm-United co-CEO Fady Fares says the agreement is consistent with his company’s goal of allowing independent pharmacies to thrive in a highly competitive and changing market.
“This agreement will help to keep our network of pharmacies at the leading edge of medical cannabis from an educational and professional development perspective,” Fares explains in a statement.
Read more: Canntab enters $1M purchase agreement with MediPharm
Read more: Canntab launching Indigenous-only medical cannabis platform to address deadly opioid crisis
“This important relationship, with a large network of highly respected pharmacists, is a testament and recognition of the importance of the health benefits of medical cannabis as well as Canntab’s key role in delivering true pharmaceutical grade THC and CBD to those medical patients in a trusted and precise dosage format,” Canntab CEO Larry Latowsky says.
Latowsky says many of the pharmacies in the network are either in proximity or often affiliated with pain clinics, and provide necessary information required to access medical cannabis and the Canntab offerings.
The affiliation will extend and leverage their reach to a wider population, he continues, while adding a significant number of patients to Canntab’s medical portal.
The company also notes it’s received approval from the government of Saskatchewan to start selling Canntab products in their wholesale and provincial store networks. In November, the company received its medical sales licence from Health Canada.
Canntab recently announced a partnership with the leader of the Shawanaga First Nation and an Indigenous-owned indoor farming company to increase access to medical cannabis in hopes of mitigating the ongoing opioid crisis.
Follow Natalia Buendia Calvillo on Twitter